Psoriasis Area and Severity Index (PASI)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Mild0–5
- Moderate5–10
- Severe10–20
- Very Severe20–72
The Psoriasis Area and Severity Index (PASI) calculates quantifying total body surface area involvement and staging cutaneous or blistering disease severity. Key inputs include head erythema. Scores guide calculating resuscitation fluid protocols, administering topical or systemic corticosteroids, and wound care. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Quantifies the severity of psoriasis by combining assessment of lesion severity and affected body surface area. This standardized measurement tool evaluates four body regions (head, arms, trunk, legs) with scoring for erythema, induration, and desquamation, providing an objective assessment for clinical practice and research.
Clinical Indication
The Psoriasis Area and Severity Index (PASI) is indicated for bedside clinical practice to support Quantifies the severity of psoriasis by combining assessment of lesion severity and affected body surface area. This standardized measurement tool evaluates four body regions (head, arms, trunk, legs) with scoring for erythema, induration, and desquamation, providing an objective assessment for clinical practice and research.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute thermal burns, extensive bullous eruptions, severe psoriasis, or severe cutaneous adverse reactions. Clinical application is indicated across Dermatology clinics, burn centers, and emergency dermatology triage.
Limitations & Contraindications
Rule of Nines overestimates burn surface area in pediatric anatomy; Lund-Browder charts must be utilized.
Clinical Pearls & Action Plan
Full-body cutaneous examination including all mucous membranes and scalp is necessary to detect early epidermal detachment.
PASI = 0.1 × (E_h + I_h + D_h) × A_h + 0.2 × (E_a + I_a + D_a) × A_a + 0.3 × (E_t + I_t + D_t) × A_t + 0.4 × (E_l + I_l + D_l) × A_l
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| head_erythema | integer | Yes | Erythema (redness) severity in head/neck region(score) |
| head_induration | integer | Yes | Induration (thickness) severity in head/neck region(score) |
| head_desquamation | integer | Yes | Desquamation (scaling) severity in head/neck region(score) |
| head_area | integer | Yes | Percentage of head/neck area affected by psoriasis(score) |
| arms_erythema | integer | Yes | Erythema (redness) severity in upper limbs/arms region(score) |
| arms_induration | integer | Yes | Induration (thickness) severity in upper limbs/arms region(score) |
| arms_desquamation | integer | Yes | Desquamation (scaling) severity in upper limbs/arms region(score) |
| arms_area | integer | Yes | Percentage of upper limbs/arms area affected by psoriasis(score) |
| trunk_erythema | integer | Yes | Erythema (redness) severity in trunk region(score) |
| trunk_induration | integer | Yes | Induration (thickness) severity in trunk region(score) |
| trunk_desquamation | integer | Yes | Desquamation (scaling) severity in trunk region(score) |
| trunk_area | integer | Yes | Percentage of trunk area affected by psoriasis(score) |
| legs_erythema | integer | Yes | Erythema (redness) severity in lower limbs/legs region(score) |
| legs_induration | integer | Yes | Induration (thickness) severity in lower limbs/legs region(score) |
| legs_desquamation | integer | Yes | Desquamation (scaling) severity in lower limbs/legs region(score) |
| legs_area | integer | Yes | Percentage of lower limbs/legs area affected by psoriasis(score) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5 | Mild | Mild psoriasis |
| 5–10 | Moderate | Moderate psoriasis |
| 10–20 | Severe | Severe psoriasis |
| 20–72 | Very Severe | Very severe psoriasis |
Evidence-Based References (EBM)
- Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. doi: 10.1159/000250839.DOI: 10.1159/000250839
- Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol. 2004;51(4):563-9. doi: 10.1016/j.jaad.2004.04.012.DOI: 10.1016/j.jaad.2004.04.012
- Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210(3):194-9. doi: 10.1159/000083509.DOI: 10.1159/000083509
- Puzenat E, Bronsard V, Prey S, Gourraud PA, Aractingi S, Bagot M, et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol. 2010;24 Suppl 2:10-6. doi: 10.1111/j.1468-3083.2009.03562.x.DOI: 10.1111/j.1468-3083.2009.03562.x